Clinical Trials at The Methodist Hospital Research Institute |
Search results... |
Heart and Blood Diseases |
| Active and enrolling clinical trials for Heart and Blood Diseases are updated on this page as they become available. You are also welcome to view our clinical trials that are registered with the National Institutes of Health. |
| |
| For more information please contact the study coordinator of the trials listed below or contact the main clinical trials help line 713-441-3250. |
| |
Arrythmias
Hansen System with ThermoCool® for Patients with PAF
Study Status: Active/Enrolling
Investigator: Valderrabano, Miguel
Study Coordinator: Tindel, Melinda
Phone: 713-441-3248
Summary:The purpose of this study is to assess the safety and performance of the Hansen Medical Sensei Robotic System and Artisan Catheter when used to robotically manipulate the Biosense ThermoCool ablation ...(read more)
IRASE AF
Study Status: Active/Enrolling
Investigator: Rami, Tapan
Study Coordinator: Tindel, Melinda
Phone: 713-441-3248
Summary:The purpose of this study is to test the safety and effectiveness of an Irrigated Ablation System for the treatment of symptomatic paroxysmal atrial fibrillation.(read more)
|
Atherosclerosis and Arteriosclerosis
Ovation
Study Status: Active/Enrolling
Investigator: Lumsden, Alan
Study Coordinator: Josey, Jennifer
Phone: 713-441-4628
Summary:The primary objectives of this study are to determine whether the TriVascular AAA Stent Graft is a safe and effective method of treating abdominal aortic aneurysms (AAA's) in those patients considered...(read more)
VM202
Study Status: Active/Enrolling
Investigator: Davies, Mark
Study Coordinator: Bass, Anastasia
Phone: 713-441-6539
Summary:The purpose of this study is to evaluate whether intramuscular injections of VM202 into the calf is safe and effective in the treatment of critical limb ischemia(read more)
|
Coronary Artery Disease
EXAMINE
Study Status: Active/Enrolling
Investigator: Hamilton, Dale
Study Coordinator: Whipple, Melissa
Phone: 713-441-3247
Summary:The purpose of this study is to evaluate the cardiovascular outcomes of alogliptin, once daily (QD), compared with placebo, in addition to standard of care, in subjects with type 2 diabetes mellitus a...(read more)
EXCEL
Study Status: Active/Enrolling
Investigator: Shah, Alpesh
Study Coordinator: Sosa, Lenis
Phone: 713-441-3245
Summary:To establish the safety and efficacy of the XIENCE PRIME or XIENCE V Everolimus Eluting Coronary Stent System (EECSS) in subjects with unprotected left main coronary artery disease by comparing to cor...(read more)
EXPERT CTO
Study Status: Active/Enrolling
Investigator: Shah, Alpesh
Study Coordinator: Sosa, Lenis
Phone: 713-441-3245
Summary:A prospective, multi-center, single-arm study to establish the safety and effectiveness of the XIENCE V® Everolimus Eluting Coronary Stent, XIENCE nano™ Everolimus Eluting Coronary Stent, HT PROGRESS ...(read more)
IRASE AF
Study Status: Active/Enrolling
Investigator: Rami, Tapan
Study Coordinator: Tindel, Melinda
Phone: 713-441-3248
Summary:The purpose of this study is to test the safety and effectiveness of an Irrigated Ablation System for the treatment of symptomatic paroxysmal atrial fibrillation.(read more)
|
Embolism and Thrombosis
Ovation
Study Status: Active/Enrolling
Investigator: Lumsden, Alan
Study Coordinator: Josey, Jennifer
Phone: 713-441-4628
Summary:The primary objectives of this study are to determine whether the TriVascular AAA Stent Graft is a safe and effective method of treating abdominal aortic aneurysms (AAA's) in those patients considered...(read more)
VM202
Study Status: Active/Enrolling
Investigator: Davies, Mark
Study Coordinator: Bass, Anastasia
Phone: 713-441-6539
Summary:The purpose of this study is to evaluate whether intramuscular injections of VM202 into the calf is safe and effective in the treatment of critical limb ischemia(read more)
|
Heart Defects
AC-058B201 Echocardiographic Ancillary Study
Study Status: Active/Enrolling
Investigator: Nagueh, Sherif
Study Coordinator: Frias, Maria
Phone: 713-441-2849
Summary:Multicenter, Randomized, Double-blind, Parallel-group Extension to Study AC-058B201 to Investigate the Long-term Safety, Tolerability, and Efficacy of Three Doses of ACT-128800, an Oral S1P1 Receptor ...(read more)
Corevalve Extreme Risks Patients
Study Status: Active/Enrolling
Investigator: Kleiman, Neal
Study Coordinator: Green, LaShawna
Phone: (713) 441-6548
Summary:The purpose of the study is to evaluate the safety and efficacy of the Medtronic CoreValve® System in the treatment of symptomatic severe aortic stenosis in subjects who have a predicted high risk for...(read more)
CoreValve High Risk Surgical Patients
Study Status: Active/Enrolling
Investigator: Reardon, Michael
Study Coordinator: Green, LaShawna
Phone: (713) 441-6548
Summary:The purpose of the study is to evaluate the safety and efficacy of the Medtronic CoreValve® System in the treatment of symptomatic severe aortic stenosis in subjects who have a predicted high risk for...(read more)
|
Heart Failure
Freedom Driver
Study Status: Active/Enrolling
Investigator: Bruckner, Brian
Study Coordinator: Bunge, Raquel
Phone: 713-441-6509
Summary:The purposes of this study are to confirm that the Freedom Driver System is a suitable pneumatic driver for clinically stable TAH-t subjects, and that patients and lay caregivers can be trained to man...(read more)
SynCardia TAH-t PM Surveillance Study
Study Status: Active/Enrolling
Investigator: Bruckner, Brian
Study Coordinator: Bunge, Raquel
Phone: 713-441-6509
Summary:The purpose of this study is to demonstrate that the results achieved in the original pivotal clinical investigation of 81 subjects from five clinical sites are generalizable to new clinical sites tha...(read more)
|
Heart Transplant
Freedom Driver
Study Status: Active/Enrolling
Investigator: Bruckner, Brian
Study Coordinator: Bunge, Raquel
Phone: 713-441-6509
Summary:The purposes of this study are to confirm that the Freedom Driver System is a suitable pneumatic driver for clinically stable TAH-t subjects, and that patients and lay caregivers can be trained to man...(read more)
SynCardia TAH-t PM Surveillance Study
Study Status: Active/Enrolling
Investigator: Bruckner, Brian
Study Coordinator: Bunge, Raquel
Phone: 713-441-6509
Summary:The purpose of this study is to demonstrate that the results achieved in the original pivotal clinical investigation of 81 subjects from five clinical sites are generalizable to new clinical sites tha...(read more)
|
Myocardial Ischemia
EXAMINE
Study Status: Active/Enrolling
Investigator: Hamilton, Dale
Study Coordinator: Whipple, Melissa
Phone: 713-441-3247
Summary:The purpose of this study is to evaluate the cardiovascular outcomes of alogliptin, once daily (QD), compared with placebo, in addition to standard of care, in subjects with type 2 diabetes mellitus a...(read more)
EXCEL
Study Status: Active/Enrolling
Investigator: Shah, Alpesh
Study Coordinator: Sosa, Lenis
Phone: 713-441-3245
Summary:To establish the safety and efficacy of the XIENCE PRIME or XIENCE V Everolimus Eluting Coronary Stent System (EECSS) in subjects with unprotected left main coronary artery disease by comparing to cor...(read more)
EXPERT CTO
Study Status: Active/Enrolling
Investigator: Shah, Alpesh
Study Coordinator: Sosa, Lenis
Phone: 713-441-3245
Summary:A prospective, multi-center, single-arm study to establish the safety and effectiveness of the XIENCE V® Everolimus Eluting Coronary Stent, XIENCE nano™ Everolimus Eluting Coronary Stent, HT PROGRESS ...(read more)
|
Stroke
AMERICA
Study Status: Active/Enrolling
Investigator: Diaz, Orlando
Study Coordinator: Bautista, Marilyn
Phone: 713-441-1409
Summary:Ten study centers from US are anticipated to participate for this evaluation. Published literature on coils with electrolytic, thermal or hydraulic detachment will serve as the basis for control compa...(read more)
GTN
Study Status: Active/Enrolling
Investigator: Diaz, Orlando
Study Coordinator: Bautista, Marilyn
Phone: 713-441-1409
Summary:The current proposal describes a post-market, clinical registry of HydroSoft, aimed at gaining robust clinical data in a large set of patients to better define the advantages, and potentially, the dis...(read more)
|
